| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/10/2004 | CA2317896C Method for in vitro amplification of circular dna |
| 08/10/2004 | CA2263063C Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| 08/10/2004 | CA2243985C Thermostable dna polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes |
| 08/10/2004 | CA2090904C Dna detection method |
| 08/07/2004 | CA2418582A1 A method for simulating and modeling the presence and growth of microbes, including pathogens and spoilage organisms through a food supply chain |
| 08/05/2004 | WO2004066185A1 Methods for analyzing polymer populations |
| 08/05/2004 | WO2004065939A2 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
| 08/05/2004 | WO2004065938A2 Human osteoporosis gene |
| 08/05/2004 | WO2004065935A2 System and method determining sizes of polynucleotides |
| 08/05/2004 | WO2004065932A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | WO2004065931A2 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on bmp2 and coliai linkage |
| 08/05/2004 | WO2004065635A2 Laser exposure of photosensitive masks for dna microarray fabrication |
| 08/05/2004 | WO2004065634A1 Method for determining polynucleotide sequence variations |
| 08/05/2004 | WO2004065633A1 Method of using peptidyl arginine deiminase type iv |
| 08/05/2004 | WO2004065632A1 Method of judging tumor (cancer) or tumor (cancer) metastasis |
| 08/05/2004 | WO2004065631A1 Probe conjugation to increase multiplex binding motif preference |
| 08/05/2004 | WO2004065630A1 Detection of predisposition to osteoporosis |
| 08/05/2004 | WO2004065629A1 Circulating mrna as diagnostic markers for pregnancy-related disorders |
| 08/05/2004 | WO2004065628A1 Quantitative multiplex detection of nucleic acids |
| 08/05/2004 | WO2004065627A1 Method and kit for early diagnosis of fungal infection (pyricularia oryzae) in rice |
| 08/05/2004 | WO2004065626A2 A method of sepsis prognosis |
| 08/05/2004 | WO2004065625A1 Assay for detecting methylation changes in nucleic acids using an intercalating nucleic acid |
| 08/05/2004 | WO2004065624A1 Measuring device and method for the detection of dna sequence |
| 08/05/2004 | WO2004065623A2 Assay for inhibitors of isph |
| 08/05/2004 | WO2004065622A1 Method of detecting drug resistance |
| 08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | WO2004065617A2 Haplotype analysis |
| 08/05/2004 | WO2004065616A2 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 08/05/2004 | WO2004065602A1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc |
| 08/05/2004 | WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER |
| 08/05/2004 | WO2004065592A2 The crystal structure of a catalytically active portion of a set 7/9 histone methyltransferase and uses thereof |
| 08/05/2004 | WO2004065583A2 Gene expression markers for breast cancer prognosis |
| 08/05/2004 | WO2004065582A2 Amplification of dna in a hairpin structure, and applications |
| 08/05/2004 | WO2004065570A2 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces |
| 08/05/2004 | WO2004065563A2 Ndr kinase modulators |
| 08/05/2004 | WO2004065553A2 Method for comprehensive identification of cell lineage specific genes |
| 08/05/2004 | WO2004065550A2 Nucleic acid amplification using non-standard bases |
| 08/05/2004 | WO2004065545A2 Diagnosis and prognosis of breast cancer patients |
| 08/05/2004 | WO2004065542A2 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 08/05/2004 | WO2004064987A2 Method |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064784A2 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | WO2004064783A2 Eosinophil-derived neurotoxin as a marker for ovarian cancer |
| 08/05/2004 | WO2004064782A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 08/05/2004 | WO2004064773A2 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | WO2004064768A2 Animal model for alzheimer's disease |
| 08/05/2004 | WO2004064748A2 Compositions and methods for treatment of ovarian cancer |
| 08/05/2004 | WO2004064739A2 Substrate detection assay |
| 08/05/2004 | WO2004064737A2 Therapeutics compositions |
| 08/05/2004 | WO2004064736A2 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | WO2004064735A2 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | WO2004064711A2 Modulation of deubiquitinase family members |
| 08/05/2004 | WO2004064710A2 Applications of substances binding to gstm for the diagnosis and treatment of cystic carcinomas |
| 08/05/2004 | WO2004064612A2 Regulation of tgf-b signaling by tomoregulin |
| 08/05/2004 | WO2004064601A2 Amplified and overexpressed gene in colorectal cancers |
| 08/05/2004 | WO2004064537A2 Method for the in situ production of an emulsifier in foodstuff |
| 08/05/2004 | WO2004064482A2 Alien sequences |
| 08/05/2004 | WO2004057025A3 Method for determining the presence of one or more ligands in a sample |
| 08/05/2004 | WO2004055216A3 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells |
| 08/05/2004 | WO2004054366A3 Screening methods for membrane binding fungicides |
| 08/05/2004 | WO2004053165A9 Methods and compositions relating to gradient exposed cells |
| 08/05/2004 | WO2004053160A3 Method to analyze polymeric nucleic acid sequence variations |
| 08/05/2004 | WO2004053146A3 Sec14 as an antifungal target |
| 08/05/2004 | WO2004053145A3 Trl1 as an antifungal target |
| 08/05/2004 | WO2004046342A3 Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas |
| 08/05/2004 | WO2004043370A3 Methods and compositions for modulating activator protein 1 |
| 08/05/2004 | WO2004042389A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) |
| 08/05/2004 | WO2004042359A3 Preformulation analysis and optimization |
| 08/05/2004 | WO2004042085A3 Method for quantifying a ratio between at least two nucleic acid sequences |
| 08/05/2004 | WO2004042073A3 Method for detecting nucleic acids |
| 08/05/2004 | WO2004041216A3 Ptpn11 (shp-2) mutations and cancer |
| 08/05/2004 | WO2004039837A3 Crh responsive genes in cns |
| 08/05/2004 | WO2004037989A3 Modified nucleotides and methods of labeling nucleic acids |
| 08/05/2004 | WO2004035810A3 Verfahren zur bestimmung der enzymatischen aktivität des lytb- und gcpe-proteins |
| 08/05/2004 | WO2004031912A3 Methods for estimating haplotype frequencies and disease associations with haplotypes and environmental variables |
| 08/05/2004 | WO2004029622A3 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 08/05/2004 | WO2004029023A3 Cell-surface estrogen receptor and related compositions and methods |
| 08/05/2004 | WO2004027031A3 Tryptophan hydroxylase assay |
| 08/05/2004 | WO2004024875A3 Mammalian megakaryocyte progenitor cell |
| 08/05/2004 | WO2004024283A3 Apparatus and method for preparative scale purification of nucleic acids |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022770A3 Compositions and methods for synthesizing nucleic acids |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004019864A3 Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| 08/05/2004 | WO2004011938A3 Method and device for screening molecules in cells |
| 08/05/2004 | WO2004005465A3 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 08/05/2004 | WO2003087054A3 Methods for identifying compounds that modulate enzymatic activity |
| 08/05/2004 | WO2003085115A3 Identification and validation of novel targets for agrochemicals |
| 08/05/2004 | WO2003081209A3 Identification of ligands for a receptor family and related methods |
| 08/05/2004 | WO2003060163A8 Discrimination and detection of target nucleotide sequences using mass spectrometry |
| 08/05/2004 | WO2003058252A3 Test strip for determining concentration of multiple analytes in a single fluid sample |
| 08/05/2004 | WO2003054550A8 Uses of an endothelial cell receptor |
| 08/05/2004 | WO2003054512A3 Identification of an amplified gene and target for drug intervention |
| 08/05/2004 | WO2003048729A3 Discovery of therapeutic products |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003031591A3 Detecting targets by unique identifier nucleotide tags |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |